SCHEMBL6927281

SCHEMBL6927281

CC(C)c1cccc(C(C)C)c1N1C(=O)c2ccccc2C1=S

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 5/20 1.00
NR1H2 P55055 1/20 1.00
NR1H3 Q13133 1/20 1.00
ANPEP P15144 5/20 0.58
FAAH O00519 1/20 0.40
MGLL Q99685 1/20 0.40
KMT2A Q03164 3/20 0.40
LMNA P02545 1/20 0.37
CASP3 P42574 1/20 0.37
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2820118 0.88 DPP4 (0.78) DPP4NR1H2NR1H3ANPEPFAAH
SCHEMBL29366407 0.88 DPP4 (0.78) DPP4NR1H2NR1H3ANPEPFAAH
SCHEMBL6923966 0.88 DPP4 (0.78) DPP4NR1H2NR1H3ANPEPFAAH
SCHEMBL10718972 0.80 DPP4 (0.65) DPP4NR1H2NR1H3ANPEPKMT2A
SCHEMBL29379602 0.79 DPP4 (0.65) DPP4NR1H2NR1H3ANPEPKMT2A
SCHEMBL9612014 0.78 DPP4 (0.63) DPP4NR1H2NR1H3ANPEPFAAH
SCHEMBL29382416 0.76 DPP4 (0.61) DPP4NR1H2NR1H3ANPEPFAAH
SCHEMBL17531021 0.76 ANPEP (0.67) DPP4NR1H2NR1H3ANPEPFAAH
SCHEMBL30954668 0.76 ANPEP (0.67) DPP4NR1H2NR1H3ANPEPFAAH
SCHEMBL300362 0.75 DPP4 (0.61) DPP4NR1H2NR1H3ANPEPKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3404059-B1 METHOD FOR MANUFACTURING SURFACE-MODIFIED THERMOPLASTIC RESIN NITTO DENKO CORP (JP) 2023-03-01 EP disclosed
CN-115284695-A Bonded structure, thermal transfer surface-modified sheet, thermoplastic resin with modified sheet, and surface-modified thermoplastic resin 日东电工株式会社 2022-11-04 CN disclosed
US-6515129-B1 A pharmaceutical composition which comprises, a cyclic imide derivative represented by the general formula (I): present invention relates to an aminopeptidase N inhibitor or an angiogenesis inhibitor, modulates production of tumor necrosis ISHIHARA SANGYO KAISHA LTD. (JP) 2003-02-04 US disclosed
US-6429212-B1 AMINOPEPTIDASE N INHIBITOR USED TO TREAT CANCER, TUMORS, AND RETINOPATHY; FEW SIDE EFFECTS; ANGIOGENESIS INHIBITOR ISHIHARA SANGYO KAISHA LTD. (JP) 2002-08-06 US disclosed